M MALLINCKRODT

Serial Number 85646928
606

Registration Progress

Application Filed
Jun 8, 2012
Under Examination
Jul 16, 2013
Approved for Publication
May 21, 2013
Published for Opposition
May 21, 2013
Registered

Trademark Image

M MALLINCKRODT

Basic Information

Serial Number
85646928
Filing Date
June 8, 2012
Published for Opposition
May 21, 2013
Abandonment Date
February 17, 2014
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 17, 2014
Classes
001 005 010

Rights Holder

Mallinckrodt Brand Pharmaceuticals, Inc.

03
Address
675 McDonnell Boulevard
Hazelwood, MO 63042

Ownership History

Mallinckrodt Brand Pharmaceuticals, Inc.

Original Applicant
03
Hazelwood, MO

Mallinckrodt Brand Pharmaceuticals, Inc.

Owner at Publication
03
Hazelwood, MO

Legal Representation

Attorney
Mark A. Nieds

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

24 events
Date Code Type Description Documents
Feb 18, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Feb 17, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 16, 2013 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 16, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
May 21, 2013 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 21, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 1, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 15, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 10, 2013 ALIE A ASSIGNED TO LIE Loading...
Mar 20, 2013 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 20, 2013 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 20, 2013 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 20, 2013 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 20, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 19, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 18, 2013 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 18, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 25, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 25, 2012 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 25, 2012 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 25, 2012 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 19, 2012 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Jun 18, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 12, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating pain, cough and upper respiratory symptoms, opioid addiction, behavioral disorders, diabetes, and prostate cancer; Excipients and chemical additives for use in the manufacture of pharmaceuticals and food; Chemicals for use in the manufacture of radiopharmaceuticals
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Pharmaceutical preparations for the treatment of pain, cough and upper respiratory symptoms, opioid addiction, insomnia, depression, and behavioral disorders; contrast media for use in medical imaging procedures; radiopharmaceutical preparations for use in nuclear medicine; Pharmaceutical kits for making radiopharmaceutical diagnostic preparations; syringes sold filled with saline solution
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Non-invasive power injectors used for subcutaneous injection of medicine and imaging solutions for medical imaging procedures and component parts therefor; Medical apparatus for warming contrast media; Medical generators for use in the production and transportation of nuclear medicine and component parts therefor; Radioaerosol generators, namely, nebulizers for administering radioactive medicine and imaging solutions in gaseous form for medical imaging procedures and component parts therefor; Elution shields, namely, nuclear medicine radiation apparatus for collection of sodium-pertechnetate from Mo99/ Tc99m generators and radiation shielding; Medical imaging apparatus and instruments in the field of urology, and component parts therefor
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the stylized word "MALLINCKRODT" appearing to the right of a three dimensional rectangular design containing interlocking triangular, square and cubical shapes forming the letter "M" in the foreground.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001 005 010